Enterochromaffin Cells (EC cells) are specialized neuroendocrine cells scattered throughout the lining of the gastrointestinal tract, particularly in the mucosa of the small intestine and colon. These cells play a crucial role in gut physiology by releasing various signaling molecules, including serotonin, in response to stimuli such as mechanical distension and chemical changes in the luminal contents. Serotonin released by EC cells acts as a neurotransmitter and a paracrine signaling molecule, influencing gut motility, secretion, and sensation. The serotonin released by EC cells in the gut is involved in the regulation of peristalsis, mucosal blood flow, and intestinal immune responses. Imbalances in serotonin signaling from EC cells have been implicated in gastrointestinal disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Additionally, EC cells contribute to the gut-brain axis, influencing mood and behavior. Research on enterochromaffin cells provides valuable insights into the intricate communication between the digestive system and the nervous system, offering potential targets for therapeutic interventions in gastrointestinal and neurological disorders.
Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cells for human disease modelling and potential for tissue repair
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : The role of gingival fibroblasts in periodontal diseases and regeneration
Katarzyna Gawron, Medical University of Silesia in Katowice, Poland
Title : Personalized and Precision Medicine (PPM): A unique healthcare model via pathology-related modelling and bi-odesign-inspired translational applications for the next gen-eration of human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation